Securing Reagent Supplies and Scaling COVID-19 [Funder: Genome BC, UBC]
- Funded by Other Funders (Canada)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Other Funders (Canada)Principal Investigator
Drs. Martin Hirst, Natalie Prystajecky, Mel Krajden, Marco Marra, Robin Coope, Gregg Morin, Rob Holt, Agatha Jassem, Thibault Mayor, Sheila Teves, Ivan Sadowski…Research Location
CanadaLead Research Institution
University of British Columbia, BCCDCResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
As the COVID-19 pandemic expands around the world, the BC Centre for Disease Control and other testing sites are facing two dire problems: a shortage in reagents and the personnel needed to ramp-up diagnostic testing. In the immediate term the project team will ensure that BC can maintain and expand its capacity for COVID-19 testing by making sure that reagent sources can be sourced locally. In the medium term, these reagents will be further validated, and production scaled up to meet the accelerating testing demands in BC. The establishment of molecular resources, protocols and formulations will also ensure that BC and Canada are prepared to meet future pandemics in the face of disrupted global supply chains. Ultimately, a stable supply of reagents, produced locally, will allow expansion of testing to mild/asymptomatic cases, resulting in enhanced contact tracing and isolation that will limit onward transmission.